Frankfurt - Delayed Quote EUR
Pfizer Inc. (PFEB.F)
7.55
+0.70
+(10.22%)
At close: June 13 at 2:13:27 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 24 | 23 |
| Avg. Estimate | 13.43B | 17.11B | 62.44B | 62.24B |
| Low Estimate | 13.1B | 16.72B | 60.6B | 59.17B |
| High Estimate | 13.66B | 17.82B | 63.96B | 64.38B |
| Year Ago Sales | 13.28B | 17.7B | 63.63B | 62.44B |
| Sales Growth (year/est) | 1.08% | -3.33% | -1.86% | -0.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PFEB.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Related Tickers
ABBV.MX AbbVie Inc.
3,651.91
+0.38%
4AB.BE AbbVie Inc
165.20
-0.36%
DSKYF Daiichi Sankyo Company, Limited
23.50
-9.72%
RHO.HM Roche Holding AG
304.60
-1.30%
AMG.F Amgen Inc.
257.95
+0.31%
ABBV.NE AbbVie Inc.
27.33
-0.47%
RHHBF Roche Holding AG
337.50
-4.12%
AZN.L AstraZeneca PLC
10,986.00
-0.40%
GSK.L GSK plc
1,511.50
-2.45%
GSK GSK plc
40.86
-3.84%